Alere Company

Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.


Connections from

Total Funding: $512 000 000
Headquarters: Waltham, Massachusetts, United States
Funding Status: M&A
Estimated Revenue: $1B to $10B
Last Funding Type: Post-IPO Equity
Technology: Genetic Test & Molecular Diagnostics
Last Funding Date: 2017-08-14
Founded Date: 01.01.1981
Industry: Diagnostics